Assessing Medical Student Interest in Training About Medications for Opioid Use Disorder: A Pilot Intervention

Assessing Medical Student Interest in Training About Medications for Opioid Use Disorder: A Pilot Intervention
复制标题

DOI:
10.1177/2382120520923994
复制
发表时间:
2020-05-01
影响因子:
2.8
通讯作者:
Lagisetty, Pooja
Lagisetty, Pooja
中科院分区:
其他
文献类型:
--
作者:
Thomas, Jennifer;Slat, Stephanie;Lagisetty, Pooja

文献摘要

被引文献

相似文献

目的:对医学生进行丁丙诺啡教育可以通过解决耻辱感,消除在实践中完成培训的必要性,并将其作为一种药理学选择进行规范化,从而减少为阿片类药物使用障碍(OUD)提供治疗的障碍。我们进行了需求评估,以衡量学生在丁丙诺啡豁免培训的兴趣和试点测试的在线课程,在人的讨论的可行性和acceptability.METHODS:所有2019年毕业的学生进行了调查,以评估在完成丁丙诺啡豁免培训的兴趣,并了解他们更喜欢接受培训的格式。感兴趣的学生收到了关于免费在线丁丙诺啡豁免课程和与教师进行可选的面对面案例讨论的信息。基线和后续调查被用来评估intervention.RESULTS:出228名学生接触,173(75.9%)回答至少有一个调查。在228人中,62人(27.2%)回答了询问学生接受丁丙诺啡豁免培训的初步调查。166名未回答的学生被发送第二次调查,111名(66.9%)学生回答。在这111人中,29人(26.1%)表示他们忘记回答第一次调查,24人(21.6%)没有看到调查。在62名感兴趣的学生中,41名学生(66.1%)希望在线和面对面培训相结合。在62名学生中,30名(48.4%)感兴趣的学生完成了在线课程,10名(16.1%)参加了案例讨论。虽然没有显着差异,更高比例的学生(88.9%)表示可能会开丁丙诺啡后参加的情况下讨论比完成后的在线课程只(69.2%)。结论:这项评估表明,大多数医学生愿意完成丁丙诺啡豁免课程。反馈表明,面对面的组成部分可以增加未来的处方超过一个只在线课程,和额外的广告可能会导致更高的参与。
OBJECTIVE: Educating medical students about buprenorphine may lessen barriers to providing treatment for opioid use disorder (OUD) by addressing stigma, removing the need to complete training while practicing, and normalizing it as a pharmacological option. We conducted a needs assessment to measure student interest in buprenorphine waiver training and pilot tested an online course with an in-person discussion for feasibility and acceptability.METHODS: All 2019 graduating students were surveyed to assess interest in completing buprenorphine waiver training and understand in which format they preferred to receive the training. Interested students received information about a free online buprenorphine waiver course and an optional in-person case discussion with a faculty member. Baseline and follow-up surveys were used to assess the intervention.RESULTS: Out of 228 students contacted, 173 (75.9%) responded to at least 1 survey. Of the 228, 62 (27.2%) responded to the initial survey asking students about receiving buprenorphine waiver training. The 166 non-responding students were sent a second survey, and 111 (66.9%) students responded. Of those 111, 29 (26.1%) indicated they forgot to respond to the first survey, and 24 (21.6%) did not see the survey. Of the 62 interested students, 41 students (66.1%) wanted a combination of online and in-person training. Of the 62, 30 (48.4%) interested students completed the online course and 10 (16.1%) attended the case discussion. While not significantly different, a higher proportion of students (88.9%) indicated being likely to prescribe buprenorphine after attending the case discussion than after completing the online course only (69.2%).CONCLUSIONS: This assessment suggested that most of the medical students are willing to complete a buprenorphine waiver course. Feedback indicated an in-person component could increase future prescribing more than an online-only curriculum, and additional advertising could result in higher participation.